| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 182.90M | 185.20M | 184.30M | 174.20M | 132.90M | 142.30M |
| Gross Profit | 56.50M | 122.10M | 126.20M | 116.60M | 86.70M | 81.50M |
| EBITDA | 100.40M | 38.50M | -157.10M | 97.40M | 70.10M | -209.90M |
| Net Income | -75.90M | 5.40M | -192.50M | -37.80M | 123.90M | -235.70M |
Balance Sheet | ||||||
| Total Assets | 2.35B | 2.47B | 2.53B | 2.84B | 2.51B | 2.59B |
| Cash, Cash Equivalents and Short-Term Investments | 1.30M | 25.30M | 11.60M | 18.50M | 49.00M | 191.00M |
| Total Debt | 864.30M | 876.00M | 889.50M | 943.60M | 626.50M | 779.10M |
| Total Liabilities | 955.40M | 968.30M | 982.50M | 1.05B | 712.30M | 874.10M |
| Stockholders Equity | 1.40B | 1.50B | 1.55B | 1.79B | 1.80B | 1.72B |
Cash Flow | ||||||
| Free Cash Flow | 67.20M | 15.50M | 51.90M | 74.90M | 56.70M | 36.00M |
| Operating Cash Flow | 68.50M | 76.60M | 53.90M | 78.80M | 57.90M | 38.40M |
| Investing Cash Flow | 10.90M | 16.50M | 45.90M | -200.20M | 9.20M | -14.90M |
| Financing Cash Flow | -79.90M | -72.00M | -106.70M | 90.90M | -209.10M | 90.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £3.65B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | £1.16B | 5.45 | 7.18% | 2.52% | 12.73% | ― | |
63 Neutral | £1.80B | 12.12 | 4.48% | 3.93% | 2.30% | ― | |
57 Neutral | £672.90M | -2.68 | -5.24% | 7.31% | -1.67% | -120.18% | |
50 Neutral | £217.97M | 35.14 | 5.91% | 2.71% | -14.09% | ― | |
42 Neutral | £1.74B | 126.90 | ― | 0.36% | -2.24% | ― |